Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial.
| Image |  |
|---|---|
| Description | scientific article published on 03 March 2016 |
| Author/s |
author: Philippe Gabriel Steg |
| Publication date | March 3, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |